BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 17496580)

  • 1. Therapy of nontuberculous mycobacterial disease.
    Griffith DE
    Curr Opin Infect Dis; 2007 Apr; 20(2):198-203. PubMed ID: 17496580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in the treatment of nontuberculous mycobacterial (NTM) disease.
    Griffith DE; Wallace RJ
    Semin Respir Infect; 1996 Dec; 11(4):301-10. PubMed ID: 8976583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series.
    Davis KK; Kao PN; Jacobs SS; Ruoss SJ
    BMC Pulm Med; 2007 Feb; 7():2. PubMed ID: 17319962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium avium complex and other nontuberculous mycobacterial infections in patients with HIV.
    Chin DP
    Semin Respir Infect; 1993 Jun; 8(2):124-38. PubMed ID: 8278680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
    Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ
    Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Kuijper EJ
    Future Microbiol; 2014; 9(9):1095-110. PubMed ID: 25340838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of infections due to Mycobacterium avium complex.
    Kasperbauer SH; Daley CL
    Semin Respir Crit Care Med; 2008 Oct; 29(5):569-76. PubMed ID: 18810690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with rifabutin in the treatment of mycobacterial infections.
    De Cian W; Sassella D; Wynne BA
    Scand J Infect Dis Suppl; 1995; 98():22-6. PubMed ID: 8867175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and investigational therapies for AIDS-associated Mycobacterium avium complex disease.
    Rathbun RC; Martin ES; Eaton VE; Matthew EB
    Clin Pharm; 1991 Apr; 10(4):280-91. PubMed ID: 2032445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of refractory nontuberculous mycobacterial lung disease.
    Griffith DE; Aksamit TR
    Curr Opin Infect Dis; 2012 Apr; 25(2):218-27. PubMed ID: 22327466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung disease caused by nontuberculous mycobacteria.
    Alvarez-Uria G
    Curr Opin Pulm Med; 2010 May; 16(3):251-6. PubMed ID: 20154623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
    Watanabe M; Hasegawa N; Ishizaka A; Asakura K; Izumi Y; Eguchi K; Kawamura M; Horinouchi H; Kobayashi K
    Ann Thorac Surg; 2006 Jun; 81(6):2026-30. PubMed ID: 16731124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antimycobacterial agents.
    Cynamon MH; Klemens SP
    Clin Chest Med; 1989 Sep; 10(3):355-64. PubMed ID: 2505963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.
    Jhun BW; Kim SY; Moon SM; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2018 Nov; 198(10):1322-1330. PubMed ID: 29877739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nontuberculous mycobacteriosis; the present status and in the future. 3--(1). The view of development of new drugs against nontuberculous mycobacterial infections].
    Kawahara S; Nagare H
    Kekkaku; 1998 Feb; 73(2):77-82. PubMed ID: 9545700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
    Griffith DE; Brown BA; Cegielski P; Murphy DT; Wallace RJ
    Clin Infect Dis; 2000 Feb; 30(2):288-92. PubMed ID: 10671330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
    Ramirez J; Mason C; Ali J; Lopez FA
    J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated Mycobacterium avium complex infection: implications of recent clinical trials on prophylaxis and treatment.
    Benson CA
    AIDS Clin Rev; 1997-1998; ():271-87. PubMed ID: 9305452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.